Press "Enter" to skip to content

New patent for Novo Nordisk drug TRESIBA

0
Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug TRESIBA

Annual Drug Patent Expirations for TRESIBA
Annual Drug Patent Expirations for TRESIBA

Tresiba is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are fourteen patents protecting this drug.

Drug patent litigation for TRESIBA.

This drug has one hundred and twenty-one patent family members in twenty-three countries.

The generic ingredient in TRESIBA is insulin degludec. Two suppliers are listed for this compound. Additional details are available on the insulin degludec profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug TRESIBA
    Do NOT follow this link or you will be banned from the site!